Public Health Effectiveness of the FDA 510 Clearance Process : Measuring Postmarket Performance and Other Select Topics

By Institute of Medicine, Board on Population Health and Public Health Practice, Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process, Theresa Wizemann